SCHB ETF holdings (NYSE) - Page 114 | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

NAGE Niagen Bioscience Inc 168.3417 K 33.3350 K 0.0004%

DGICA Donegal Group Inc 166.3504 K 9 441.0000 0.0004%

WOLF Wolfspeed Inc 164.0310 K 8 318.0000 0.0004%

agilon health Inc 162.3009 K 275.4130 K 0.0004%

CTNM Contineum Therapeutics Inc 161.0700 K 10.5000 K 0.0004%

TBRG Computer Programs & Systems Inc 161.0329 K 8 348.0000 0.0004%

SPCE Virgin Galactic Holdings Inc 160.6831 K 63.0130 K 0.0004%

LXRX Lexicon Pharmaceuticals Inc 159.7126 K 108.6480 K 0.0004%

OSUR OraSure Technologies Inc 159.6294 K 50.6760 K 0.0004%

SSP EW Scripps Co/The 158.0403 K 38.0820 K 0.0004%

RXST RxSight Inc 157.7756 K 21.0930 K 0.0004%

CMTG Claros Mortgage Trust Inc 157.4532 K 65.8800 K 0.0004%

GRNT Granite Ridge Resources Inc 157.2041 K 31.0680 K 0.0004%

GBFH GBank Financial Holdings Inc 157.0920 K 5 200.0000 0.0004%

UPB Upstream Bio Inc 156.7949 K 20.4160 K 0.0004%

XPER Xperi Inc 156.7073 K 25.5640 K 0.0004%

MVIS MicroVision Inc 156.6137 K 200.5040 K 0.0004%

KROS Keros Therapeutics Inc 156.5866 K 11.0350 K 0.0004%

EVMN Evommune Inc 156.0000 K 6 000.0000 0.0004%

OABI OmniAb Inc 155.6101 K 90.4710 K 0.0004%

Notizie

SCHB: SCHB: A Hold Amid Premium Valuations And Higher Risk-Free Rates (NYSEARCA:SCHB)

Large Caps - Big Opportunity

3 Reasons Why I Remain Bullish On SCHB, And 2 To Sell It Immediately (NYSEARCA:SCHB)

Q1 2026 Dividend Check-In: Highest Quarterly Hike Percentage Since 2019

Big Tech's $635B AI Push Meets Energy Crunch: ETFs to Diversify

Patience Pays: ETFs You Can Buy and Hold for the Long Run

3 Best ETFs to Invest In, According to AI Analyst, 2/5/2026 - TipRanks.com

SCHB: The Conflict Between Short- And Long-Term Risks (NYSEARCA:SCHB)

ETFs to Keep Your Portfolio on Track in the Long Term

SCHB: Core Equity Holding For Diversified Investors (NYSEARCA:SCHB)

Capital Markets Outlook Q4 2025: Kicking The Can Down The Tightrope

Equity Outlook: From Caution To Complacency?